BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/16/2019 5:25:43 AM | Browse: 844 | Download: 1983
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 42426
Country China
ISSN 1948-5204 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
Manuscript Source Unsolicited Manuscript
All Author List Yue-Lu Zhu, Yong-Kun Sun, Xue-Min Xue, Jiang-Ying Yue, Lin Yang and Li-Yan Xue
Funding Agency and Grant Number
Funding Agency Grant Number
CAMS Innovation Fund for Medical Sciences 2016-I2M-3-005
Beijing Hope Run Special Fund LC2015A03
Beijing Hope Run Special Fund LC2013B34
Corresponding Author Li-Yan Xue, MD, Professor, Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 PanJiaYuanNanLi, Chaoyang District, Beijing 100021, China. xuely@cicams.ac.cn
Key Words Gastric cancer; Neoadjuvant chemotherapy; Lymph nodes; Regression; Residual tumor; Regression change
Core Tip Neoadjuvant chemotherapy has been applied worldwide to improve the survival of patients with gastric adenocarcinoma (GAC). In this study, we evaluated the prognostic effect of regression change in lymph nodes (LNs) from 192 GAC patients treated with neoadjuvant chemotherapy. The existence of residual tumor in LNs, rather than regression change in LNs, is useful for predicting prognosis after neoadjuvant chemotherapy in GAC patients. In practice, it may not be necessary to report regression change in LNs.
Publish Date 2019-01-15 08:49
Citation Zhu YL, Sun YK, Xue XM, Yue JY, Yang L, Xue LY. Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 2019; 11(1): 48-58
URL https://www.wjgnet.com/1948-5204/full/v11/i1/48.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i1.48
Full Article (PDF) WJGO-11-48.pdf
Full Article (Word) WJGO-11-48.docx